A Bayesian multi-stage cost-effectiveness design for animal studies in stroke research
- 1 April 2018
- journal article
- research article
- Published by SAGE Publications in Statistical Methods in Medical Research
- Vol. 27 (4), 1219-1229
- https://doi.org/10.1177/0962280216657853
Abstract
Much progress has been made in the area of adaptive designs for clinical trials. However, little has been done regarding adaptive designs to identify optimal treatment strategies in animal studies. Motivated by an animal study of a novel strategy for treating strokes, we propose a Bayesian multi-stage cost-effectiveness design to simultaneously identify the optimal dose and determine the therapeutic treatment window for administrating the experimental agent. We consider a non-monotonic pattern for the dose-schedule-efficacy relationship and develop an adaptive shrinkage algorithm to assign more cohorts to admissible strategies. We conduct simulation studies to evaluate the performance of the proposed design by comparing it with two standard designs. These simulation studies show that the proposed design yields a significantly higher probability of selecting the optimal strategy, while it is generally more efficient and practical in terms of resource usage.Keywords
This publication has 20 references indexed in Scilit:
- Threats to Validity in the Design and Conduct of Preclinical Efficacy Studies: A Systematic Review of Guidelines for In Vivo Animal ExperimentsPLoS Medicine, 2013
- A call for transparent reporting to optimize the predictive value of preclinical researchNature, 2012
- Survey of the Quality of Experimental Design, Statistical Analysis and Reporting of Research Using AnimalsPLOS ONE, 2009
- Expansion of the Time Window for Treatment of Acute Ischemic Stroke With Intravenous Tissue Plasminogen ActivatorStroke, 2009
- Human and economic burden of strokeAge and Ageing, 2008
- Adaptive design methods in clinical trials – a reviewOrphanet Journal of Rare Diseases, 2008
- Translating animal research into clinical benefitBMJ, 2007
- “Telestroke”Stroke, 1999
- Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS)Jama-Journal Of The American Medical Association, 1995
- Group Sequential Clinical Trials: A Classical Evaluation of Bayesian Decision-Theoretic DesignsJournal of the American Statistical Association, 1994